Cureskin, the AI-driven dermatology platform, announced on Wednesday that it has raised $20 million in Series B funding. The round was led by HealthQuad, along with participation from existing investors like JSW Ventures and Khosla Ventures. CEO Guna Kakulapati stated that these funds will enhance AI capabilities and accelerate growth.
With this latest investment, Cureskin’s total funding now stands at $26 million, supporting its mission to provide quality dermatological care in India. Managing Director of HealthQuad, Pinak Shrikhande, highlighted the platform’s focus on customized skin and hair treatments, using AI-led diagnosis for affordable regimens. JSW Ventures Managing Partner, Sachin Tagra, emphasized that the capital will help Cureskin scale operations and innovate on AI development.
Cureskin has treated over 15 lakh customers through its mobile app, addressing various skin and hair conditions. With a significant customer base in tier 2 and 3 regions, the platform aims to bridge the gap in access to dermatological care. The company’s commitment to providing high-quality, outcome-driven solutions at affordable prices has garnered support from investors and customers alike.
